Revvity

Biotechnology Research

Oxford Immunotec is now Revvity. There are a global, high-growth diagnostics company focused on developing and commercializing proprietary assays for immunology and infectious disease. The Company’s T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered in Milton Park near Oxford, U.K. and in Marlborough, MA.